Monkasta

Medicinal product

(Invented) name

Monkasta

Active substance (s)

Montelukastas

Strength

4 mg

Pharmaceutical form

kramtomosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03DC03, Montelukast

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2020-02-28

Date of renewal

Documents

1213_Monkasta_4mg_kramt_tab_PZPL_2020-02-28.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Montelukastas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103393	89495	1089495	lizdinė plokštelė	N28		Receptinis	LT/L/20/1213/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-02-28	Registruotas